P. Aiden McCormick
About
In The Last Decade
P. Aiden McCormick
199 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 144
- Hepatology 2.7k
- Epidemiology 2.5k
- Surgery 1.8k
- Gastroenterology 369
- Pulmonary and Respiratory Medicine 354
Countries citing papers authored by P. Aiden McCormick
This map shows the geographic impact of P. Aiden McCormick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Aiden McCormick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Aiden McCormick more than expected).
Fields of papers citing papers by P. Aiden McCormick
This network shows the impact of papers produced by P. Aiden McCormick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Aiden McCormick. The network helps show where P. Aiden McCormick may publish in the future.
Co-authorship network of co-authors of P. Aiden McCormick
This figure shows the co-authorship network connecting the top 25 collaborators of P. Aiden McCormick. A scholar is included among the top collaborators of P. Aiden McCormick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Aiden McCormick. P. Aiden McCormick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 1 | |
| 5 | 44 | |
| 6 | 8 | |
| 7 | 162 | |
| 8 | 46 | |
| 9 | 63 | |
| 10 | The effect of the combination of octreotide and metoclopramide on azygos blood flow in cirrhotic patients with portal hypertension | 6 |
| 11 | Nitric oxide synthase inhibitors in the hepatorenal syndrome | 2 |
| 12 | 62 | |
| 13 | Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension | 55 |
| 14 | 49 | |
| 15 | 45 | |
| 16 | 67 | |
| 17 | RANDOMIZED TRIAL OF LONGTERM SCLEROTHERAPY FOR VARICEAL REBLEEDING USING THE SAME PROTOCOL TO TREAT REBLEEDING IN ALL PATIENTS - FINAL REPORT | 1 |
| 18 | Assessment of bleeding risk in chronic liver disease | 2 |
| 19 | VARICEAL BLEEDING - IMPORTANCE OF THE TIME INTERVAL BETWEEN ADMISSION AND STARTING POINT FOR ANALYSIS OF SURVIVAL AND REBLEEDING | 2 |
| 20 | 22 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.